BELLUS Health Inc. Gains 16.53%
Tue, Sep 14, 2021 at 05:30 PM
BELLUS Health Inc. (BLU:NASDAQ) soared at $5.57, representing a gain of 16.5%. On Mon, Sep 13, 2021, BLU:NASDAQ touched a New 2-Week High of $4.78. The stock appeared on our News Catalysts scanner on Mon, Sep 13, 2021 at 09:33 AM in the 'BIOTECH' category. From Mon, Aug 30, 2021, the stock recorded 66.67% Up Days and 50.00% Green Days
About BELLUS Health Inc. (BLU:NASDAQ)
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.
Top 10 Gainers:
- Communications Systems, Inc. (JCS:NASDAQ), 39.41%
- OG (OG:NYSE), 30.59%
- CYREN Ltd. (CYRN:NASDAQ), 26.73%
- IRNT (IRNT:NYSE), 20.27%
- NanoViricides, Inc. (NNVC:NYSEMKT), 18.67%
- Calumet Specialty Products Partners, L.P. (CLMT:NASDAQ), 17.43%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 17.41%
- BELLUS Health Inc. (BLU:NASDAQ), 16.53%
- NRXP (NRXP:NASDAQ), 15.12%
- ADGI (ADGI:NASDAQ), 14.81%